| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $290.6M | +11.0% |
| Cost of Revenue | $60.0M | +16.8% |
| Gross Profit | $230.5M | +9.6% |
| R&D Expense | $69.1M | +19.7% |
| SG&A Expense | $29.8M | +17.9% |
| Operating Income | $47.1M | +7.2% |
| Interest Expense | $5.9M | — |
| Pre-tax Income | $52.4M | -9.8% |
| Income Tax | $10.3M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $306.7M | +205.4% |
| Accounts Receivable | $62.1M | -19.1% |
| Inventory | $18.0M | -18.1% |
| Current Assets | $476.0M | +54.9% |
| Total Assets | $629.8M | +45.5% |
| Current Liabilities | $133.7M | +8.2% |
| Long-term Debt | $218.8M | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $84.9M | -6.2% |
| Capital Expenditures | $20.1M | +64.1% |
| Investing Cash Flow | -$243.6M | -403.9% |
| Financing Cash Flow | $134.8M | +404.5% |
| Free Cash Flow | $64.8M | -17.2% |
| +29.2% |
| Net Income | $42.1M | -16.0% |
| EPS (Basic) | $0.58 | -14.7% |
| EPS (Diluted) | $0.57 | -14.9% |
| Total Liabilities |
| $418.3M |
| +108.1% |
| Stockholders' Equity | $211.5M | -8.7% |